8-K: Marchex Directors Re-Elected, New Stock Options Granted
Annual Meeting Results and Corporate Governance Update
Marchex, Inc. announced the re-election of its directors and new compensation arrangements including stock options and quarterly cash payments following its 2025 annual meeting.
Summary
- Marchex held its 2025 annual meeting of stockholders on December 16, 2025.
- All director nominees were re-elected to the Board of Directors.
- Stockholders ratified the selection of the independent registered public accounting firm.
- The Compensation Committee approved grants of 50,000 stock options to each director as compensation for annual board service.
- These options have an exercise price equal to the closing price of the Class B common stock on December 16, 2025.
- Options will vest over two years, with 50% vesting on the first and second annual anniversaries of the grant date, and fully upon a Change in Control.
- Each independent director will also receive $7,500 in cash per quarter for their annual board service.
Sentiment
Score: 7
Explanation: The filing reports routine corporate governance matters, including the re-election of directors and the ratification of the independent auditor, which are standard positive outcomes. The new director compensation package, which includes stock options, aligns director incentives with shareholder value, contributing to a slightly positive sentiment.
Positives
- Continuity in leadership with all director nominees re-elected by stockholders.
- Stockholders ratified the selection of the independent registered public accounting firm, indicating sound corporate governance.
- New director compensation structure, including stock options, aligns director incentives with long-term shareholder value.
Future Outlook
Stock options granted to directors will vest over a two-year period, with 50% vesting on the first and second annual anniversaries of the grant date, and full vesting upon a Change in Control.
Industry Context
The re-election of directors, ratification of an independent auditor, and the approval of director compensation packages, including equity incentives, are standard corporate governance practices for publicly traded companies, aiming to ensure board continuity and align leadership interests with shareholder value.
Comparison to Industry Standards
- This filing does not provide specific financial or operational results that would allow for a direct comparison to global benchmarks or specific comparable companies/projects.
- Director compensation structures vary widely across the industry, but the inclusion of stock options is a common practice to incentivize long-term performance and align director interests with those of shareholders.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Re-election | All director nominees (Michael Arends, Dennis Cline, Donald Cogsville, Russell Horowitz, M. Wayne Wisehart) were re-elected to the Board of Directors. | December 16, 2025 | Ensures continuity and stability of the Board's leadership. |
| Auditor Ratification | Stockholders ratified the selection of the independent registered public accounting firm. | December 16, 2025 | Confirms shareholder confidence in the company's financial oversight and reporting. |
| Director Compensation Structure | Approved stock option grants of 50,000 options to each director under the 2021 Stock Incentive Plan, with a two-year vesting schedule. Also approved $7,500 cash per quarter for independent directors. | December 16, 2025 | Aligns director incentives with long-term shareholder value through equity and provides competitive cash compensation for board service. |
Stakeholder Impact
- Shareholders: Benefit from continuity of board leadership and director incentives aligned with stock performance through equity grants.
- Directors: Receive new compensation package including stock options and quarterly cash payments for their service.
Next Steps
- Vesting of director stock options over the next two years, with 50% on the first and second anniversaries of the December 16, 2025 grant date.
Key Dates
| Date | Description |
|---|---|
| December 16, 2025 | Annual Meeting of Stockholders held; Grant Date for stock options to directors. |
| December 17, 2025 | Date of signing the Current Report on Form 8-K. |
Keywords
Marchex, 8-K, annual meeting, director election, stock options, executive compensation, corporate governance, auditor ratification
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.